SI-BONE, Inc.
NASDAQ:SIBNMedical - Devices
+$0.53 today
- Market cap
- $1.06B
- Beta
- 0.70
- P/E (TTM)
- -41.4
- EPS (TTM)
- -$0.38
Volume 1.12M
Average 0.68M
SIBN Net Income
Bottom-line profit, the starting point for calculating cash from operations.
SI-BONE, Inc.NASDAQ: SIBN
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income declines year over year
Q1 FY2026 net income of $4.33M (cash outflow) fell 33.8% year over year, ahead of the -37.1% change in trailing-twelve-month net income. Sequentially, it rose 163.6% from the prior quarter. Over 3 fiscal years it compounded at -32.4% a year.
Context
- Net income amounted to 9.4% of revenue in FY2025, down 9.1 pp from a year earlier.
- Net income grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 6 analysts of -$14.96M (-20.8%) for the fiscal year ending Dec 2026, a step up from the -38.8% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$4.33M+163.6% QoQ
- Last fiscal yearDec 2025
- -$18.9M-38.8% YoY
- LTMMar 2026
- -$16.7M-37.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -33.8% | +4.8% | +38.5 pp |
| 1 year | -38.8% | -20.8% | +18.0 pp |
| 3-year CAGR | -32.4% | -22.9% | +9.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (18.9M) USD
- Year-over-year change
- +38.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (18.9M) | +38.8% |
| FY2024 | 2024-12-31 | (30.91M) | +28.7% |
| FY2023 | 2023-12-31 | (43.34M) | +29.3% |
| FY2022 | 2022-12-31 | (61.26M) | -8.3% |
| FY2021 | 2021-12-31 | (56.57M) | — |
Net Income vs competitors
How SIBN compares with its peers on the latest reported figures
- SIBN's LTM Mar 2026 net income of $16.7M is the smallest of the 6 companies compared; the peer median is $535.43M.
- Its year-over-year change of -37.1% is the 5th highest of 6, against a peer median of +27.8%.
- Net income amounts to 8.1% of revenue for SIBN, versus a peer median of 14.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.73B | +27.8% | +11.2% | 14.4% | |
| FY2025 | $625M | +51.7% | +41.0% | 10.1% | |
| LTM Jun 2026 | $535.43M | +50.1% | +41.4% | 17.0% | |
| LTM Mar 2026 | $125.36M | -24.3% | -1.8% | 15.9% | |
| LTM Mar 2026 | $54.85M | -53.8% | — | 4.0% | |
| LTM Mar 2026 | $16.7M | -37.1% | -32.4% | 8.1% | |
| Peer median (excluding SIBN) | $535.43M | +27.8% | +26.1% | 14.4% | |
Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (56.57M) | (61.26M) | (43.34M) | (30.91M) | (18.9M) |
| Depreciation & Amortization | 2.09M | 3.45M | 5.43M | 4.38M | 2.72M |
| Deferred Income Tax | 3.56M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 16.87M | 23.06M | 24.06M | 25.87M | 25.52M |
| Change in Working Capital | (5.76M) | (7.64M) | (4.83M) | (10.12M) | (14.33M) |
| Accounts Receivables | (569K) | (6.48M) | (2.12M) | (5.84M) | (3.03M) |
| Inventory | (5.78M) | (5.71M) | (4.72M) | (8.05M) | (8.68M) |
| Accounts Payables | (532K) | 2.53M | (1.12M) | 1.86M | (1.76M) |
| Other Working Capital | 1.13M | 2.02M | 3.13M | 1.91M | (851K) |
| Other Non-Cash Items | 288K | 730K | (29K) | (1.64M) | 4.31M |
| Operating Cash Flow | (39.53M) | (41.66M) | (18.71M) | (12.43M) | (675K) |
| Capital Expenditures | (6.39M) | (9.51M) | (7.8M) | (10.5M) | (8.41M) |
| Acquisitions (Net) | (57.97M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (102.02M) | (119.51M) | (189.5M) | (205.38M) | (192.53M) |
| Sales of Investments | 159.99M | 126.2M | 137.5M | 228.5M | 205.1M |
| Other Investing Activities | 57.97M | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 51.58M | (2.82M) | (59.8M) | 12.62M | 4.16M |
| Debt Repayment | (6.62M) | 0 | 725K | (46K) | 0 |
| Common Stock Issued | 4.91M | 2.2M | 83.67M | 2.72M | 3.38M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 6.54M | (720K) | 0 |
| Financing Cash Flow | (1.71M) | 2.2M | 90.93M | 1.96M | 3.38M |
| Effect of Forex Changes | (498K) | (429K) | 132K | (479K) | 431K |
| Net Change in Cash | 9.84M | (42.7M) | 12.55M | 1.68M | 7.29M |
| Free Cash Flow | (45.92M) | (51.16M) | (26.51M) | (22.92M) | (9.09M) |
SI-BONE, Inc.
NASDAQ:SIBN
Intrinsic Alpha fair value
Locked
Current Price
$23.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.